Navigation Links
Academic Researcher of the Year 2007
Date:9/7/2007

Neil Marlow, Professor of Neonatal Medicine at The University of Nottingham, has been recognised for his extensive research into the care and treatment of newborn babies, particularly those born prematurely, with an award for Academic Researcher of the Year.

The award, by the Good Clinical Practice Journal (GCPj), acknowledges the critical role that academics and academic institutions play in drug development and clinical trials. It is given to the individual who has produced the most important piece of clinical research, resulting in a major new drug candidate, target or therapeutic approach for the pharmaceutical or biotech industries.

Professor Neil Marlow said: I am deeply honoured to receive this award. I am delighted that it has come to someone in perinatal and newborn medicine as it is an area where huge strides have been made through clinical trials to make childbirth safer for the baby and to improve the long term outcomes for some of the most vulnerable members of our society. I couldn't have achieved this without the support of a fantastic team of colleagues and co-researchers from medicine, psychology and many other disciplines in Nottingham and around the country. This is really a tribute to the dedication and application of the researchers who work in such a difficult field.

Professor Marlow has carried out extensive research into the care and treatment of newborn babies, particularly those who are born extremely prematurely. Throughout his career as a neonatologist, he has retained a firm research interest in outcome evaluation following perinatal adversity.

Among Professor Marlows current major research projects is the EPICure study, the first in the UK, to study a group of babies born extremely prematurely and follow them longitudinally through into adolescence. The results of this study, funded by the Medical Research Council (MRC), are helping to improve understanding of the many challenges faced by ba
'/>"/>

Contact: Professor Neil Marlow
neil.marlow@nottingham.ac.uk
University of Nottingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Dealing With Stress Results In Better Academic Performance
2. Children should eat well to do well in academics say experts!
3. Extensive Academic Work Envisaged On Effects of Smoking Ban
4. Academics Question Veracity Of NHS IT Upgrade Plan
5. Physical Activity Determines Academic Performance
6. Meningitis in Infancy Erodes Academic Success
7. BMA Calls for Action to Halt Slide in Medical Academic Recruitment
8. Hyperactivity and Poor Academic Success Linked to Common Genetic Influences
9. Too Much TV Watching Linked With Poor Academic Performance in Teens
10. Social Dealings at Three can Predict Future Academic Performance
11. Nutritious Diet Help Improve Childrens Academic Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Quintessa Medical ... Kybella is a nonsurgical treatment designed specifically for the elimination of excess ... of the first locations in the state of Wisconsin to offer this innovative treatment. ...
(Date:7/30/2015)... ... 30, 2015 , ... The Tisch Cancer Institute at Icahn ... Tisch Cancer Institute (TCI) at the Icahn School of Medicine at Mount Sinai ... elite group of 69 cancer institutions nationwide that have earned this designation, which ...
(Date:7/30/2015)... ... July 30, 2015 , ... Author Dr. Raul Llanos seeks ... in his new self-help book, “ Consciously Healing our Webs of Health, Wellbeing, Success, ... message: “If we take responsibility for ourselves, we can create better realities.” His book ...
(Date:7/30/2015)... ... 30, 2015 , ... WellSpan Health in York, Pa., has ... claims for bariatric surgery that, despite complying with national and local coverage determinations, ... nurse auditor at WellSpan Health, tells Atlantic Information Services’ (AIS) Report on Medicare ...
(Date:7/30/2015)... ... ... weight, many people place a lot of focus on the different types of food that need ... another key component to successful weight gain is knowing when to eat so that ... Gainer gives three tips on when to eat to gain weight. , The first thing ...
Breaking Medicine News(10 mins):Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 2Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 3Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3
... a part of National Health Service (NHS) that offers support to ... has decided// to cut hundreds of jobs as part of a ... going on about the issue. But unions fear that as many ... set up eight years ago as a new approach to take ...
... that periodontal disease is not a desirable condition in ... the first time researchers from Case Western Reserve University ... and Gynecology at MetroHealth Medical Center in Cleveland have ... ,Their report, titles, "Transmission of an Uncultivated Bergeyella Strain ...
... India the Reserve Bank of India (RBI) is not allowing ... and the State Bank of India (SBI) // facing difficulties ... , The Comprehensive Economic Cooperation Agreement (CECA) that was ... The Monetary Authority of Singapore (MAS), or central bank, ...
... people who suffer whiplash injuries can recover soon with ... Quebec, Canada.// The Whiplash Management strategy is a big ... initiative being better cost economy and earlier resumption of ... target, better practices in management of patient care that ...
... with inherited retinal degeneration have hope of vision since ... light sensitive that were not before.// ,Zhuo-Hua ... colleagues have engineered this technology using a harmless virus, ... "inner retinal neurons" in a strain of mice with ...
... of Kaiser Permanente, overweight or obesity during one’s middle ... in life. ,'The study was presented during ... San Diego. ,The researchers from the Kaiser ... 9,000 people for a period of 30 years. ...
Cached Medicine News:Health News:Strained Economic Agreement Between Singapore And India 2Health News:There is light at the end of the blind tunnel: prosthetic retinal cells offer hope! 2
(Date:7/30/2015)... 2015   HeartWare International, Inc . (NASDAQ: ... invasive, miniaturized circulatory support technologies that are revolutionizing ... total revenue of $73.6 million for the quarter ... for the quarter ended June 30, 2014.  Currency ... or nine percentage points, during the three months ...
(Date:7/30/2015)... Maine, July 30, 2015  IDEXX Laboratories, Inc. (NASDAQ: ... quarter of 2015 of $413 million, an increase of ... the strengthening of the US dollar reduced reported revenue ... for the quarter was 11%, supported by strong growth ... per diluted share ("EPS") was $0.60 for the quarter, ...
(Date:7/29/2015)... FRANCISCO , July 29, 2015 Dignity ... Francis Orthopedic Institute, combining the services of the hospital,s ... in one centralized location, and expanding services to include ... the street from Saint Francis Memorial Hospital at 1199 ... Institute is a premier center aimed at providing a ...
Breaking Medicine Technology:HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 5HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 6HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 7HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 8HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 9HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 10HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 11HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 12HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 13HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 14IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23
...   , First once-daily, fixed-dose ... (an irregular heartbeat) at risk of the devastating consequences ... single drug solution for the treatment of deep vein ... Xarelto is now approved in the UK for ...
... 19, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... Products for Human Use (CHMP) of the European Medicines ... facility expansion in Novato, CA.  Final approval by the ... which would allow for products manufactured at the facility ...
Cached Medicine Technology:Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 2Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 3Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 5Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 6BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility 2BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility 3